Sunday, September 27, 2020
wellness India Expo
Home Tags AstraZeneca

Tag: AstraZeneca

Astrazeneca’s diabetes drug, Dapagliflozin shows positive results for CKD in global...

AstraZeneca’s dapagliflozin is the first medicine in SGLT-2i class to move into a new disease area by demonstrating efficacy and safety data for the treatment of patients with CKD...................

India-Sweden Healthcare Innovation Centre launches ‘Innovation Challenge’

India-Sweden Healthcare innovation centre is a collaboration between the Swedish Trade Commissioner’s Office, All India Institute of Medical Sciences, New Delhi (AIIMS Delhi) and All India Institute of Medical Sciences, Jodhpur (AIIMS Jodhpur).......................

Wockhardt partners UK Govt to manufacture Oxford COVID-19 vaccine

As per the terms of the agreement the company has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK Government in its fight against COVID- 19, including AZD1222, the vaccine co-invented by the University of Oxford...............

DCGI nod to Serum Institute for conducting human trials of Oxford...

The Drugs Controller General of India has given the Serum Institute of India a green light to conduct phase 2 and 3 human trials of the Oxford-AstraZeneca COVID-19 vaccine candidate in India..................

IQVIA & AstraZeneca team-up to support development of potential COVID-19 vaccine

Operation Warp Speed is part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.......................

Sun Pharma & AstraZeneca enter into license agreement for novel oncology...

As per the terms of the agreement, Sun Pharma will be responsible for development, regulatory filings and manufacturing the products covered in the agreement while AstraZeneca will exclusively promote and distribute these products in China...................

AstraZeneca set to expand its clinical research footprint in India

The establishment of a new Development Operations Centre by AstraZeneca at Bengaluru supports the development of innovative medicines and hosts clinical trial experts focused on core therapeutic areas................

AstraZeneca announces finalists of the Unnati Healthcare Innovation Challenge, joins hands...

AstraZeneca strengthens innovation partnerships with NASSCOM – CoE IoT and Unnati to address Non-Communicable Diseases (NCDs) in India. Leif Johansson, Non-Executive Chairman of the Board, AstraZeneca PLC visits India...…………...

AstraZeneca well placed to use Medtech to expand in Chinese healthcare...

The Chinese Internet giants will develop smart health services, AI-assisted screening and diagnosis tools for the British pharma giant...……….

AstraZeneca receives marketing permission for Durvalumab (ImfinziTM) in India

Durvalumab is the only immunotherapy approved for patients with unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) and was granted US FDA ‘breakthrough therapy’ designation on July 31, 2017.....................